Home > Insider Trading > Filing (0001104659-22-099001)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1787640	Convey Health Solutions Holdings Inc.	CNVY	Services-Misc Health & Allied Services, Nec (8090)	842099378

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1867588	Susana Pichardo	C/O Convey Health Solutions 100 Se Third Avenue, 26Th Floor Fort Lauderdale FL 33394	Svp, Accounting	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value $0.01 Per Share	Acquisiton	2022-09-07	41,795	$7.94	41,795	No	4	X	Direct
Common Stock, Par Value $0.01 Per Share	Acquisiton	2022-09-07	29,856	$6.76	71,651	No	4	X	Direct
Common Stock, Par Value $0.01 Per Share	Disposition	2022-09-07	71,651	$10.50	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	X	Direct
No	4	X	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $0.01 Per Share	Stock Option (right to buy)	Disposition	2022-09-07	41,795	$0.00	41,795	$7.94
Common Stock, Par Value $0.01 Per Share	Stock Option (right to buy)	Disposition	2022-09-07	29,856	$0.00	29,856	$6.76

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2030-03-02	No	4	X	Direct
47,765		2030-03-02	No	4	X	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.49 to $10.515, inclusive. The reporting person undertakes to provide to Convey Health Solutions Holdings, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The options, together representing a right to purchase 119,416 shares, consist of (i) 59,708 time-vesting options and (ii) 59,708 performance-vesting options. Time-vesting options are subject to a five-year time-based vesting schedule, with 20% vesting on September 4, 2020 and the remainder vesting in 16 equal installments every three months thereafter. Performance-vesting options vest over a five-year performance period commencing in 2019, with 20% of the stock options eligible to vest each year of the performance period based on achievement of certain financial metrics.
Exercise price reflects a reduction of $1.18 per award from original exercise price of $7.94 as part of a special dividend as previously disclosed in the Company's proxy statement for its 2022 annual meeting of stockholders.